Other OTC Pharmaceuticals - Bahrain

  • Bahrain
  • In Bahrain, the revenue generated in the Other OTC Pharmaceuticals market amounted to US$41.84m in 2024.
  • It is projected to grow annually by 1.42% (CAGR 2024-2029).
  • When compared globally, the in the United States leads in revenue generation with US$7,171.00m in 2024.
  • In terms of per person revenues, in Bahrain generated US$27.92 in 2024.
  • Bahrain's Other OTC Pharmaceuticals market is witnessing a surge in demand for traditional herbal remedies and natural health supplements.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Bahrain is experiencing steady growth due to several factors. Customer preferences for over-the-counter medications, increasing health awareness, and a growing aging population are driving the demand for these products. Additionally, local special circumstances such as the availability of a wide range of OTC medications and the convenience of purchasing them without a prescription contribute to the market's development.Customer preferences play a crucial role in the growth of the Other OTC Pharmaceuticals market in Bahrain. Many consumers prefer self-medication for minor ailments and rely on OTC medications to alleviate symptoms. This preference is driven by convenience, cost-effectiveness, and the perception that OTC medications are safe and effective for common health issues. As a result, the demand for OTC pharmaceuticals continues to rise.The increasing health awareness among Bahraini consumers is another factor driving the growth of the Other OTC Pharmaceuticals market. People are becoming more proactive in managing their health and are seeking accessible solutions for common ailments. OTC medications provide a convenient option for individuals to address minor health concerns without the need for a doctor's visit. This trend is particularly prevalent among the younger population who value quick relief and convenience.The aging population in Bahrain is also contributing to the growth of the Other OTC Pharmaceuticals market. As people age, they are more likely to experience chronic health conditions and rely on OTC medications to manage their symptoms. The elderly population in Bahrain is growing, creating a larger consumer base for OTC pharmaceuticals. This demographic shift is expected to continue driving the market's expansion in the coming years.In addition to customer preferences and demographic factors, local special circumstances in Bahrain contribute to the development of the Other OTC Pharmaceuticals market. Bahrain has a well-established healthcare system with a wide range of OTC medications available in pharmacies and supermarkets. This accessibility makes it easier for consumers to purchase OTC pharmaceuticals without the need for a prescription. The convenience and variety of OTC medications contribute to the market's growth.Underlying macroeconomic factors also play a role in the development of the Other OTC Pharmaceuticals market in Bahrain. The country's stable economy and high per capita income levels enable consumers to afford OTC medications. Additionally, the government's efforts to promote healthcare and wellness contribute to the growing demand for OTC pharmaceuticals. These factors create a favorable environment for the market's expansion.In conclusion, the Other OTC Pharmaceuticals market in Bahrain is growing due to customer preferences for self-medication, increasing health awareness, a growing aging population, local special circumstances, and underlying macroeconomic factors. As these trends continue, the market is expected to experience further growth in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)